| 10/24/26 |
Pfizer (PFE) |
atirmociclib for HR+/HER2- Breast Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/23/26 |
Marengo |
invikafusp alfa for Colorectal Cancer (CRC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/23/26 |
Marengo |
invikafusp alfa for Solid Tumors |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/23/26 |
Perspective Therapeutics (CATX) |
VMT-α-NET for Neuroendocrine Tumors (NET) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/23/26 |
Zentalis Pharmaceuticals (ZNTL) |
azenosertib for Ovarian Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |